Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Language English Country United States Media print-electronic
Document type Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
- MeSH
- Bortezomib administration & dosage MeSH
- Dexamethasone administration & dosage MeSH
- Humans MeSH
- Neoplasm Recurrence, Local drug therapy pathology MeSH
- Survival Rate MeSH
- Multiple Myeloma drug therapy pathology MeSH
- Follow-Up Studies MeSH
- Oligopeptides administration & dosage MeSH
- Prognosis MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Aged MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial, Phase III MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Bortezomib MeSH
- carfilzomib MeSH Browser
- Dexamethasone MeSH
- Oligopeptides MeSH
b School of Medicine National and Kapodistrian University of Athens Athens Greece
c University of Nantes Nantes France
e National University Health System Singapore
f Cancer Science Institute Singapore
g National University of Singapore Singapore
h Heidelberg Medical University Heidelberg Germany
Hospital Clínic de Barcelona Barcelona Spain
i University Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic
j CHRU Lille Hôpital Claude Huriez Lille France
k University Hospital Brno Brno Czech Republic
l Weill Cornell Medical College New York Presbyterian Hospital New York NY USA
m Institut Català d'Oncologia Institut Josep Carreras Hospital Germans Trias i Pujol Barcelona Spain
National University Cancer Institute Singapore
o 1st Republican Clinical Hospital of Udmurtia Izhevsk Russia
p Department of Translational Medicine University of Eastern Piedmont Novara Italy
q University Hospital Olomouc Olomouc Czech Republic
r Universitatsklinikum Tubingen Tubingen Germany
t University of Torino Torino Italy
u Onyx Pharmaceuticals Inc an Amgen subsidiary South San Francisco CA USA
v Royal Prince Alfred Hospital Camperdown New South Wales Australia
Wilhelminen Cancer Research Institute Wilhelminenspital Vienna Austria
References provided by Crossref.org
